A Murine Model of Vertical Sleeve Gastrectomy
December 18th, 2017
11K views
The following describes the performance of vertical sleeve gastrectomy in mice. This is a type of weight-loss surgery that involves removal of approximately 70% of the stomach.
Overview
This article describes the performance of vertical sleeve gastrectomy in mice, a weight-loss surgery involving the removal of approximately 70% of the stomach. The procedure aims to model the health benefits of this surgery and its effects on obesity and related comorbidities.
Key Study Components
Area of Science
- Obesity research
- Bariatric surgery
- Animal models
Background
- Vertical sleeve gastrectomy is a common bariatric surgery.
- This method helps in understanding obesity mechanisms.
- It provides insights into potential treatments for obesity.
- The procedure is performed on mice to model human health benefits.
Purpose of Study
- To investigate the health benefits of vertical sleeve gastrectomy.
- To explore mechanisms by which bariatric surgery improves obesity.
- To identify novel targets for obesity treatment.
Methods Used
- Application of veterinary ointment to the eyes of anesthetized mice.
- Preparation of the surgical site by removing hair and disinfecting the skin.
- Use of sterile gloves and techniques during the procedure.
- Placement of sterile surgical drapes around the animal.
Main Results
- The procedure effectively models the impacts of bariatric surgery.
- It aids in understanding obesity-related health improvements.
- Facilitates research into obesity comorbidities.
- Identifies potential therapeutic targets for obesity treatment.
Conclusions
- Vertical sleeve gastrectomy in mice is a valuable research model.
- It provides insights into the mechanisms of obesity treatment.
- The findings can guide future obesity research and therapies.
Frequently Asked Questions
What is vertical sleeve gastrectomy?
It is a type of weight-loss surgery that involves removing a significant portion of the stomach.
Why use mice for this procedure?
Mice provide a model for studying the health benefits and mechanisms of bariatric surgery.
What are the benefits of this surgical model?
It helps identify novel targets for obesity treatment and understand obesity comorbidities.
What preparations are needed before the surgery?
Veterinary ointment for the eyes, hair removal, and skin disinfection are essential steps.
How does this research contribute to obesity studies?
It provides insights into how bariatric surgery can improve obesity and related health issues.
Executive Industry Relevance
This murine model of vertical sleeve gastrectomy enables mechanistic interrogation of bariatric surgery benefits beyond weight loss, supporting target validation for obesity and its comorbidities. By recapitulating human metabolic improvements such as glucose tolerance and insulin secretion, the model provides predictive confidence for de-risking therapeutic hypotheses in preclinical discovery. It positions researchers to identify novel targets for diabetes, hypertension, and cancer risk reduction linked to gastrointestinal physiology.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables therapeutic hypothesis interrogation by isolating gastrointestinal contributions to metabolic improvements post-VSG.
- Scientific Value: Supports biological de-risking through genetic and pharmaceutical manipulations in defined mouse lines to validate mechanistic contributors.
- Scientific Value: Facilitates pathway clarification by modeling effects on glucose-stimulated insulin secretion and GLP-1 release.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for assessing compound effects on energy intake, body weight, and glycemic control.
- Operational Value: Standardizes surgical reproducibility across sham and VSG cohorts for reliable longitudinal phenotyping.
- Operational Value: Provides quantitative outputs including food intake, body weight trajectories, glucose tolerance, and hormone secretion for assay readiness.
Translational & Preclinical Research
- Scientific Value: Establishes disease relevance by modeling remission of type 2 diabetes and hypertension observed in human VSG.
- Scientific Value: Supports translational biomarker alignment through measurable changes in GLP-1, insulin, and glucose dynamics.
- Strategic Value: Enables risk-adjusted advancement decisions by linking surgical mechanism to comorbidity improvement.
Pipeline & Workflow Integration
The model integrates into the discovery continuum from target validation through preclinical efficacy testing, enabling iterative refinement of mechanistic hypotheses before lead identification.
- Discovery Biology: Supports hypothesis testing of gastrointestinal mediators in obesity comorbidity resolution.
- Screening: Delivers assay-ready phenotypes with standardized metabolic readouts for compound evaluation.
- Analytics: Generates quantitative dependent variables such as AUC-GTT, insulin AUC, and GLP-1 levels for intergroup comparison.
- Translational Research: Connects discovery findings to preclinical validation via comorbidity resolution metrics.
- Enterprise Reuse: Serves as a reusable platform across genetic backgrounds, diet models, and combinatorial surgical approaches.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through mechanistic de-risking of gastrointestinal pathways.
- Operational Value: Standardization and reproducibility across laboratories using defined suture, ligation, and transection protocols.
- Strategic Value: Improved go/no-go decisions by reducing late-stage failure risk in obesity and comorbidity therapeutics.
- Portfolio Impact: Risk-adjusted prioritization of targets based on concordance with VSG-induced metabolic improvements.
Implementation Considerations
- Requires expertise in microsurgical techniques, gastrointestinal handling, and sterile rodent surgery.
- Dependent on instrumentation including dissecting microscope, spring scissors, gauze, and gavage needles for lavage.
- Necessitates cross-team standardization of sham versus VSG procedural fidelity for valid comparisons.
- Involves adaptation considerations when applying to genetically modified models with altered gastrointestinal physiology.
- Includes practical limitations such as postoperative care demands and technical variability in stomach transection consistency.
Biopharma FAQs
Why does glucose tolerance improvement matter for target validation?
Glucose tolerance improvement is a key metabolic outcome of VSG that reflects enhanced insulin sensitivity and beta-cell function, providing a quantifiable phenotype to validate targets involved in glucose homeostasis. Measuring this endpoint allows researchers to de-risk hypotheses about gastrointestinal mediators of diabetes remission.
How does isolating gastric vessel ligation contribute to mechanistic discovery?
Ligation of gastric arteries and veins isolates the vascular component of VSG, enabling researchers to distinguish between effects due to gastric resection versus altered blood flow or hypoxia signaling. This independent variable manipulation supports causal inference in pathway elucidation.
What do quantitative hormone measurements enable in preclinical assessment?
Quantitative measurements of GLP-1 and insulin secretion provide dynamic, reproducible readouts of gut-endocrine axis activation, enabling comparison across interventions and genetic models. These outputs serve as predictive biomarkers for therapeutic efficacy in obesity and diabetes models.
Why are replication requirements essential for cross-functional collaboration?
Replication ensures that metabolic improvements such as reduced energy intake and weight loss are consistent across operators, laboratories, and mouse strains, building confidence in the model’s reliability. Standardized replication supports data sharing between discovery, pharmacology, and translational teams for unified decision-making.
What statistical analysis capabilities are required before implementing this model?
Implementation requires capacity for longitudinal analysis of body weight and food intake, as well as parametric or non-parametric testing of glucose tolerance curves and hormone AUCs. Teams must be able to compare sham and VSG groups using appropriate variance modeling to detect biologically significant effects.
